65
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Real-World Effectiveness of First Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current Insights

& ORCID Icon
Pages 79-87 | Received 30 Jan 2024, Accepted 20 May 2024, Published online: 09 Jun 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.